Express Pharma
Home  »  Latest Updates  »  Alkem launches favipiravir under brand name Alfluenza

Alkem launches favipiravir under brand name Alfluenza

Favipiravir is approved by the DCGI restricted emergency use in India for the treatment of mild to moderate cases of COVID-19

0 2,161
Read Article

Alkem Laboratories has launched Favipiravir under the brand name ‘Alfluenza’ in India for the management of mild to moderate cases of COVID-19.

Favipiravir is approved by the DCGI for restricted emergency use in India.

Restricted use entails responsible medication use where every patient must have signed informed consent before treatment initiation.

 

Leave A Reply

Your email address will not be published.

Smart Pharma Packaging Technologies. Attend webinar & learn how to ensure the safety & efficacy of medicines & other healthcare supplies.
Register Now
close-image